An mRNA assay system demonstrates proteasomal-specific degradation contributes to cardiomyopathic phospholamban null mutation

  1. Rohner, E.
  2. Witman, N.
  3. Sohlmer, J.
  4. De Genst, E.
  5. Louch, W.E.
  6. Sahara, M.
  7. Chien, K.R.
Revue:
Molecular Medicine

ISSN: 1528-3658 1076-1551

Année de publication: 2021

Volumen: 27

Número: 1

Type: Article

DOI: 10.1186/S10020-021-00362-8 GOOGLE SCHOLAR lock_openAccès ouvert editor